These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1310695)

  • 1. "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.
    Hung DT; Vu TK; Wheaton VI; Charo IF; Nelken NA; Esmon N; Esmon CT; Coughlin SR
    J Clin Invest; 1992 Feb; 89(2):444-50. PubMed ID: 1310695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation.
    Hung DT; Vu TK; Wheaton VI; Ishii K; Coughlin SR
    J Clin Invest; 1992 Apr; 89(4):1350-3. PubMed ID: 1313452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thrombin high-affinity binding site on platelets is a negative regulator of thrombin-induced platelet activation. Structure-function studies using two mutant thrombins, Quick I and Quick II.
    Leong L; Henriksen RA; Kermode JC; Rittenhouse SE; Tracy PB
    Biochemistry; 1992 Mar; 31(9):2567-76. PubMed ID: 1547239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal sequence requirement of thrombin receptor agonist peptide.
    Hui KY; Jakubowski JA; Wyss VL; Angleton EL
    Biochem Biophys Res Commun; 1992 Apr; 184(2):790-6. PubMed ID: 1315534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
    Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
    Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin receptor antagonists.
    Seiler SM
    Semin Thromb Hemost; 1996; 22(3):223-32. PubMed ID: 8836006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin.
    Nimjee SM; Oney S; Volovyk Z; Bompiani KM; Long SB; Hoffman M; Sullenger BA
    RNA; 2009 Dec; 15(12):2105-11. PubMed ID: 19846574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis model.
    Harenberg J; Zokai K; Piazolo L; Fenyvesi T; Jörg I
    Semin Thromb Hemost; 2002 Aug; 28(4):379-82. PubMed ID: 12244485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual thrombin receptor system for platelet activation.
    Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
    Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct thrombin inhibitors.
    Maffrand JP
    Nouv Rev Fr Hematol (1978); 1992; 34(6):405-19. PubMed ID: 1300540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin as a common downstream target blocking both platelet and monocyte activation.
    Santilli F; Davì G
    Thromb Haemost; 2009 Feb; 101(2):220-1. PubMed ID: 19190800
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC; Teng CM
    Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the protein C activation peptide with platelets.
    Martínez-Cruz R; Canseco Mdel S; Lopez-Martínez J; Cruz PA; Pérez-Campos E; Cruz MM; Alva FC; Majluf-Cruz A; Zenteno E; Ruiz-Argüelles A
    Prep Biochem Biotechnol; 2007; 37(2):139-47. PubMed ID: 17454824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of platelet activation by thrombin: a short history.
    De Candia E
    Thromb Res; 2012 Mar; 129(3):250-6. PubMed ID: 22137742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domains specifying thrombin-receptor interaction.
    Vu TK; Wheaton VI; Hung DT; Charo I; Coughlin SR
    Nature; 1991 Oct; 353(6345):674-7. PubMed ID: 1717851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the single-stranded DNA binding site in the thrombin anion-binding exosite.
    Wu Q; Tsiang M; Sadler JE
    J Biol Chem; 1992 Dec; 267(34):24408-12. PubMed ID: 1332957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.